Ernexa Therapeutics Inc. Operating Cash Flow
Ernexa Therapeutics Inc. (ERNA) reported Operating Cash Flow of -$6.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Ernexa Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.15M.
- Ernexa Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.26M.
- Ernexa Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.15M.
- Ernexa Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.27M.
- Ernexa Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$7.02M.
- Ernexa Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$15.84M.
- Ernexa Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$20.41M.
- Ernexa Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$20.98M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$6.42M 10-Q · filed 2026-08-06 | -$7.56M derived: sum of 3 quarters · filed 2026-08-06 | -$8.84M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$2.26M 10-Q · filed 2026-05-11 | -$3.41M derived: sum of 2 quarters · filed 2026-05-11 | -$4.68M derived: sum of 3 quarters · filed 2026-05-11 | -$7.22M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$2.42M derived: sum of 2 quarters · filed 2026-03-13 | -$4.95M derived: sum of 3 quarters · filed 2026-08-06 | -$7.02M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$3.80M derived: sum of 2 quarters · filed 2026-08-06 | -$5.87M 10-Q · filed 2025-11-07 | -$9.41M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.60M 10-Q · filed 2026-08-06 | -$8.14M derived: sum of 3 quarters · filed 2026-08-06 | -$14.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$2.06M 10-Q · filed 2026-05-11 | -$5.61M derived: sum of 2 quarters · filed 2026-05-11 | -$11.89M derived: sum of 3 quarters · filed 2026-05-11 | -$14.15M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$9.83M derived: sum of 2 quarters · filed 2026-03-13 | -$12.09M derived: sum of 3 quarters · filed 2026-03-13 | -$15.84M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | -$6.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$8.54M derived: sum of 2 quarters · filed 2025-11-07 | -$12.29M 10-Q · filed 2025-11-07 | -$16.95M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | -$2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$6.01M 10-Q · filed 2025-08-13 | -$10.67M derived: sum of 3 quarters · filed 2025-08-13 | -$16.49M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$3.75M 10-Q · filed 2025-05-07 | -$8.41M derived: sum of 2 quarters · filed 2025-05-07 | -$14.23M derived: sum of 3 quarters · filed 2025-05-07 | -$18.11M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | -$4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$10.49M derived: sum of 2 quarters · filed 2025-03-12 | -$14.36M derived: sum of 3 quarters · filed 2025-03-12 | -$20.41M 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | -$5.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$9.70M derived: sum of 2 quarters · filed 2024-11-12 | -$15.75M 10-Q · filed 2024-11-12 | -$21.18M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$3.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$9.92M 10-Q · filed 2024-08-13 | -$15.36M derived: sum of 3 quarters · filed 2024-08-13 | -$21.47M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$6.05M 10-Q · filed 2024-05-14 | -$11.48M derived: sum of 2 quarters · filed 2024-05-14 | -$17.60M derived: sum of 3 quarters · filed 2024-05-14 | -$21.59M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -$5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$11.55M derived: sum of 2 quarters · filed 2024-03-14 | -$15.54M derived: sum of 3 quarters · filed 2024-03-14 | -$20.98M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$6.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$10.11M derived: sum of 2 quarters · filed 2023-11-13 | -$15.54M 10-Q · filed 2023-11-13 | -$22.37M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$3.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$9.43M 10-Q · filed 2023-08-11 | -$16.26M derived: sum of 3 quarters · filed 2023-08-11 | -$22.68M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | -$5.43M 10-Q · filed 2023-05-11 | -$12.26M derived: sum of 2 quarters · filed 2023-05-11 | -$18.69M derived: sum of 3 quarters · filed 2023-05-11 | -$25.49M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$6.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$13.25M derived: sum of 2 quarters · filed 2023-03-20 | -$20.06M derived: sum of 3 quarters · filed 2023-03-20 | -$23.49M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$6.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$13.23M derived: sum of 2 quarters · filed 2022-11-14 | -$16.66M 10-Q · filed 2022-11-14 | -$16.66M 10-Q · filed 2021-11-12 | -$18.29M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$10.23M 10-Q · filed 2022-08-11 | -$10.23M 10-Q · filed 2021-08-13 | -$11.87M derived: sum of 3 quarters · filed 2022-08-11 | -$14.28M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | -$3.43M 10-Q · filed 2022-07-01 | -$3.43M 10-Q · filed 2021-05-17 | -$5.07M derived: sum of 2 quarters · filed 2022-07-01 | -$7.47M derived: sum of 3 quarters · filed 2022-07-01 | -$9.66M derived: sum of 4 quarters · filed 2022-07-01 | |||
| 2020-12-31 | -$1.64M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | -$4.04M derived: sum of 2 quarters · filed 2022-07-01 | -$6.23M derived: sum of 3 quarters · filed 2022-07-01 | -$8.10M 10-K/A · filed 2022-07-01 | -$3.89M 10-K · filed 2021-03-11 | |||
| 2020-09-30 | -$2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$4.59M derived: sum of 2 quarters · filed 2021-11-12 | -$6.46M 10-Q · filed 2021-11-12 | -$3.28M 10-Q · filed 2020-11-13 | -$5.48M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$4.06M 10-Q · filed 2021-08-13 | -$2.45M 10-Q · filed 2020-08-07 | -$3.07M derived: sum of 3 quarters · filed 2021-08-13 | -$2.65M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | -$1.87M 10-Q · filed 2021-05-17 | -$1.17M 10-Q · filed 2020-05-20 | -$890.09K derived: sum of 2 quarters · filed 2021-05-17 | -$468.09K derived: sum of 3 quarters · filed 2021-05-17 | $90.91K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $983.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.41M derived: sum of 2 quarters · filed 2021-03-11 | $1.96M derived: sum of 3 quarters · filed 2021-03-11 | $2.74M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $422.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $981.00K derived: sum of 2 quarters · filed 2020-11-13 | $1.76M 10-Q · filed 2020-11-13 | $2.60M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $559.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.34M 10-Q · filed 2020-08-07 | $2.18M derived: sum of 3 quarters · filed 2020-08-07 | $2.46M derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | $780.00K 10-Q · filed 2020-05-20 | $1.62M derived: sum of 2 quarters · filed 2020-05-20 | $1.91M derived: sum of 3 quarters · filed 2020-05-20 | $2.27M derived: sum of 4 quarters · filed 2020-05-20 | ||||
| 2018-12-31 | $837.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $1.13M derived: sum of 2 quarters · filed 2020-03-19 | $1.49M derived: sum of 3 quarters · filed 2020-03-19 | $1.36M 10-K · filed 2020-03-19 | ||||
| 2018-09-30 | $289.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $648.00K derived: sum of 2 quarters · filed 2019-11-01 | $528.00K 10-Q · filed 2019-11-01 | $739.00K 10-Q · filed 2018-11-09 | $21.00K derived: sum of 4 quarters · filed 2019-11-01 | |||
| 2018-06-30 | $359.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $239.00K 10-Q · filed 2019-08-12 | -$268.00K derived: sum of 3 quarters · filed 2019-08-12 | -$2.02M derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | -$120.00K 10-Q · filed 2019-05-14 | -$627.00K derived: sum of 2 quarters · filed 2019-05-14 | -$2.38M derived: sum of 3 quarters · filed 2019-05-14 | $895.00K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$507.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$2.26M derived: sum of 2 quarters · filed 2019-03-22 | $1.01M derived: sum of 3 quarters · filed 2019-03-22 | $549.00K 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | -$1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.52M derived: sum of 2 quarters · filed 2018-11-09 | $1.06M 10-Q · filed 2018-11-09 | $1.11M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | $3.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $2.81M 10-Q · filed 2018-08-06 | $2.86M derived: sum of 3 quarters · filed 2018-08-06 | $2.82M derived: sum of 4 quarters · filed 2018-08-06 | ||||
| 2017-03-31 | -$466.00K 10-Q · filed 2018-05-11 | -$415.00K derived: sum of 2 quarters · filed 2018-05-11 | -$456.00K derived: sum of 3 quarters · filed 2018-05-11 | $61.00K derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $10.00K derived: sum of 2 quarters · filed 2018-03-09 | $527.00K derived: sum of 3 quarters · filed 2018-03-09 | $23.00K 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $476.00K derived: sum of 2 quarters · filed 2017-11-08 | -$28.00K 10-Q · filed 2017-11-08 | -$1.99M derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $517.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $13.00K 10-Q · filed 2017-08-04 | -$1.94M derived: sum of 3 quarters · filed 2017-08-04 | -$3.03M derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | -$504.00K 10-Q · filed 2017-05-04 | -$2.46M derived: sum of 2 quarters · filed 2017-05-04 | -$3.55M derived: sum of 3 quarters · filed 2017-05-04 | -$5.68M derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2015-12-31 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$3.04M derived: sum of 2 quarters · filed 2017-03-09 | -$5.17M derived: sum of 3 quarters · filed 2017-03-09 | -$4.18M 10-K · filed 2017-03-09 | ||||
| 2015-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$3.22M derived: sum of 2 quarters · filed 2016-11-09 | -$2.22M 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | -$2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$1.14M 10-Q · filed 2016-08-04 | ||||||
| 2015-03-31 | $995.00K 10-Q · filed 2016-05-09 | |||||||
| 2013-09-30 | $723.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $903.00K derived: sum of 2 quarters · filed 2013-11-14 | $1.07M 10-Q · filed 2013-11-14 | $2.23M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2013-06-30 | $180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $346.00K 10-Q · filed 2013-08-14 | $1.51M derived: sum of 3 quarters · filed 2013-08-14 | $1.91M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2013-03-31 | $166.00K 10-Q · filed 2013-05-13 | $1.33M derived: sum of 2 quarters · filed 2013-05-13 | $1.73M derived: sum of 3 quarters · filed 2013-11-14 | $2.07M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $1.56M derived: sum of 2 quarters · filed 2013-11-14 | $1.90M derived: sum of 3 quarters · filed 2013-11-14 | $2.16M 10-K · filed 2013-03-29 | ||||
| 2012-09-30 | $397.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $739.00K derived: sum of 2 quarters · filed 2013-11-14 | $994.00K 10-Q · filed 2013-11-14 | $867.00K derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $342.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $597.00K 10-Q · filed 2013-08-14 | $470.00K derived: sum of 3 quarters · filed 2013-08-14 | $352.00K derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $255.00K 10-Q · filed 2013-05-13 | $128.00K derived: sum of 2 quarters · filed 2013-05-13 | $10.00K derived: sum of 3 quarters · filed 2013-05-13 | -$75.00K derived: sum of 4 quarters · filed 2013-05-13 | ||||
| 2011-12-31 | -$127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$245.00K derived: sum of 2 quarters · filed 2013-03-29 | -$330.00K derived: sum of 3 quarters · filed 2013-03-29 | $574.00K 10-K · filed 2013-03-29 | ||||
| 2011-09-30 | -$118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$203.00K derived: sum of 2 quarters · filed 2012-11-09 | $701.00K 10-Q · filed 2012-11-09 | $1.33M derived: sum of 4 quarters · filed 2012-11-09 | ||||
| 2011-06-30 | -$85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $819.00K 10-Q · filed 2012-08-14 | $1.45M derived: sum of 3 quarters · filed 2012-08-14 | $2.78M derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | $904.00K 10-Q · filed 2012-05-11 | $1.53M derived: sum of 2 quarters · filed 2012-05-11 | $2.87M derived: sum of 3 quarters · filed 2012-05-11 | |||||
| 2010-12-31 | $628.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $1.96M derived: sum of 2 quarters · filed 2012-03-30 | $2.83M 10-K · filed 2012-03-30 | |||||
| 2010-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $2.20M 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | $868.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |